Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection: A Pilot Comparative Study

NCT02588820 is registered in ClinicalTrials.gov with David Garcia Cinca as lead sponsor.

NCT NCT02588820
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02588820 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Extremely Early Antiretroviral Therapy to Reduce VIral REservoir and Induce Functional CURE of HIV-1 Infection: A Pilot Comparative Study
Lead sponsor
David Garcia Cinca
Phase
Phase 3
Overall status
Unknown status
Start date
April 30, 2016
Completion date
November 30, 2018
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections